TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20459775

Group type: EXPERIMENTAL
Intervention: sirolimus-containing immunosuppression
Number of subjects: 0

Group type: COMPARATOR
Intervention: mTOR-inhibitor-free immunosuppression
Number of subjects: 0
Study: 19641760

Group type: EXPERIMENTAL
Intervention: Herbst appliance (group 1, 12 individuals, average age 12 years 4 months, treated for 8.7 months)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Mandibular protraction appliance (group 2, 15 individuals, average age 13 years 2 months, treated for 8.3 months)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (group 3, 16 individuals, average age 10 years 4 months, no treatment for 10 months)
Number of subjects: 43
Study: 15639301

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12748432

Group type: EXPERIMENTAL
Intervention: Postoperative subfascial infusion with 0.5% bupivacaine at 2 ml per hour for 48 hours
Number of subjects: 44

Group type: COMPARATOR
Intervention: Oral analgesics alone (nonpump group)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Postoperative subfascial infusion with 0.5% bupivacaine
Number of subjects: 44
Study: 10654982

Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS) 100 microg QD
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Mometasone furoate aqueous nasal spray (MFNS)
Number of subjects: 98
Study: 9049515

Group type: EXPERIMENTAL
Intervention: Total cholesterol levels ≤ 160 mg/dl
Number of subjects: 595

Group type: COMPARATOR
Intervention: Total cholesterol levels > 160 mg/dl (controls)
Number of subjects: 595
Study: 8317655

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 60
Study: 3719282

Group type: EXPERIMENTAL
Intervention: Video feedback training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional teaching
Number of subjects: 36
Study: 29656569

Group type: EXPERIMENTAL
Intervention: Small‐quantity lipid‐based nutrient supplements (SQ‐LNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron‐folic acid (IFA) capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple micronutrient (MMN) capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All supplements (SQ‐LNS, IFA, MMN)
Number of subjects: 0
Study: 27653293

Group type: EXPERIMENTAL
Intervention: TAP block with local anesthetics and dexamethasone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: PILA with dexamethasone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no regional technique)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: PILA
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 25424951

Group type: EXPERIMENTAL
Intervention: VaxiRab N
Number of subjects: 86

Group type: COMPARATOR
Intervention: Rabipur
Number of subjects: 86
Study: 23753114

Group type: EXPERIMENTAL
Intervention: GnRHa trigger (0.5 mg buserelin) followed by a single bolus of 1.500 IU hCG
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: GnRHa trigger (0.5 mg buserelin) followed by two boluses of 1.500 IU hCG
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: GnRHa trigger with one bolus of 1.500 IU hCG
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: GnRHa trigger with two boluses of 1.500 IU hCG
Number of subjects: 390
Study: 19170961

Group type: EXPERIMENTAL
Intervention: Trained group (OC+)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Untrained group (OC+ and OC-)
Number of subjects: 28
Study: 18707619

Group type: EXPERIMENTAL
Intervention: Epoetin beta 30,000 IU once weekly
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Epoetin beta 20,000 IU once weekly
Number of subjects: 50

Group type: COMPARATOR
Intervention: Epoetin beta (both doses)
Number of subjects: 50
Study: 16651750

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 20 cm2 (TNP-20x1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 20 cm2 (TNP-20x2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch 30 cm2 (TNP-30x1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cigarette smoking (12 cigarettes at 1 h intervals)
Number of subjects: 12
Study: 14672298

Group type: EXPERIMENTAL
Intervention: Meat supplementation (60-85 g/d)
Number of subjects: 555

Group type: EXPERIMENTAL
Intervention: Milk supplementation (200-250 mL/d)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Energy supplementation (isocaloric with meat and milk, 240-300 kcal/d)
Number of subjects: 555

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 555
Study: 11204322

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) measurement in children with purulent meningitis
Number of subjects: 27

Group type: COMPARATOR
Intervention: Procalcitonin (PCT) measurement in children with aseptic meningitis
Number of subjects: 27

Group type: COMPARATOR
Intervention: Procalcitonin (PCT) measurement in healthy controls
Number of subjects: 27
Study: 8611684

Group type: EXPERIMENTAL
Intervention: rhIL‐11 at 50 micrograms/kg
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: rhIL‐11 at 25 micrograms/kg
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 30891657

Group type: EXPERIMENTAL
Intervention: ICT (Inhibitory Control Training)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Sham (Control)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Gamified ICT
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Non-gamified ICT
Number of subjects: 106
Study: 30285891

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for IBS
Number of subjects: 600

Group type: COMPARATOR
Intervention: Western medicine treatment for IBS (control group)
Number of subjects: 600
Study: 26546105

Group type: EXPERIMENTAL
Intervention: Cryoablation (CRYO)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Radiofrequency (RF)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Both RF and CRYO
Number of subjects: 153
Study: 25542201

Group type: EXPERIMENTAL
Intervention: Actuated virtual keypad (AVK) system, 18 hour-long sessions (3x per week for 6 weeks)
Number of subjects: 14
Study: 22350285

Group type: EXPERIMENTAL
Intervention: Sonophoresis with SonoPrep® followed by EMLA® cream application
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham sonophoresis followed by EMLA® cream application
Number of subjects: 42
Study: 18337359

Group type: EXPERIMENTAL
Intervention: Preventive training program consisting of an exercise program of 15 minutes' duration 3 times a week, including 5 exercises for strength, flexibility, and coordination
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Placebo program consisting of 5 exercises for the upper body
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Preventive training program
Number of subjects: 1020
Study: 16600229

Group type: EXPERIMENTAL
Intervention: Hysteroscopic metroplasty including section of the cervical septum (Group A)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hysteroscopic metroplasty with preservation of the cervical septum (Group B)
Number of subjects: 28
Study: 14664421

Group type: EXPERIMENTAL
Intervention: rHuEPO 600 U/kg once weekly for three weeks plus iron supplementation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Iron supplementation only
Number of subjects: 50
Study: 10833724

Group type: EXPERIMENTAL
Intervention: Figurative strategy (combining figures in unusual ways)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Interpretative strategy (looking for unusual meanings)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control condition (no strategy suggested)
Number of subjects: 45
Study: 9425970

Group type: EXPERIMENTAL
Intervention: Single-shot spinal anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Continuous spinal anesthesia
Number of subjects: 40
Study: 8409054

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 314

Group type: COMPARATOR
Intervention: Bypass surgery
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Non-bypassed segments
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Stenosis-containing segments
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Segment occlusion
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Univariate and multivariate associations
Number of subjects: 314
Study: 2980554

Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Metrizamide
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 1400
Study: 28967235

Group type: EXPERIMENTAL
Intervention: Video-conferencing follow-up with urban-based rheumatologists and rural in-person physical therapist examiners
Number of subjects: 85

Group type: COMPARATOR
Intervention: Traditional in-person rheumatology follow-up
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study: 27565651

Group type: EXPERIMENTAL
Intervention: Investigational receptor‐specific partial agonist drug
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 24519025

Group type: EXPERIMENTAL
Intervention: Force feedback
Number of subjects: 25

Group type: COMPARATOR
Intervention: Time feedback
Number of subjects: 25
Study: 22949664

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 20399410

Group type: EXPERIMENTAL
Intervention: Facilitated group discussions
Number of subjects: 64

Group type: COMPARATOR
Intervention: Self-guided approach (newsletters)
Number of subjects: 64
Study: 18928632

Group type: EXPERIMENTAL
Intervention: rhIL-11 (25 microg/(kg.d) injected s.c. for 28 days)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (traditional hormonal therapy and immunosuppressive therapy)
Number of subjects: 26
Study: 16813184

Group type: EXPERIMENTAL
Intervention: Three phase acupuncture method
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine acupuncture method
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Difference in VAS after treatment between groups
Number of subjects: 70
Study: 14663473

Group type: EXPERIMENTAL
Intervention: Periprostatic injection anesthesia with 10 cm3 (5 cm3 each side) 1% lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 11042231

Group type: EXPERIMENTAL
Intervention: Tiagabine 2.5, 5, 7.5 or 10 mg twice daily
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Tiagabine
Number of subjects: 130
Study: 8836161

Group type: EXPERIMENTAL
Intervention: Vomeropherin pregna‐4,20‐diene‐3,6‐dione (PDD) at a concentration of 5 x 10(9) M delivered to the VNO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vomeropherin pregna‐4,20‐diene‐3,6‐dione (PDD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Identical stimuli delivered to nasal respiratory epithelium or olfactory epithelium
Number of subjects: 0
Study: 1595823

Group type: EXPERIMENTAL
Intervention: Added-purpose task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single-purpose task
Number of subjects: 30
Study: 3883742

Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31199210

Group type: EXPERIMENTAL
Intervention: Vortioxetine 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine 15 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duloxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vortioxetine (after 52 weeks)
Number of subjects: 0
Study: 29908336

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) with praise and financial incentives targeted at abstinence from opiates or attendance at treatment sessions
Number of subjects: 155000

Group type: COMPARATOR
Intervention: No contingency management (CM)
Number of subjects: 155000
Study: 27737664

Group type: EXPERIMENTAL
Intervention: etoricoxib 60 mg
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: etoricoxib 90 mg
Number of subjects: 1015

Group type: COMPARATOR
Intervention: naproxen 1000 mg
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: etoricoxib 60 mg (escalated to 90 mg)
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: etoricoxib 90 mg (continued)
Number of subjects: 1015

Group type: COMPARATOR
Intervention: naproxen 1000 mg (continued)
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 1015
Study: 26034743

Group type: EXPERIMENTAL
Intervention: Workshop ergonomic training
Number of subjects: 503

Group type: COMPARATOR
Intervention: Pamphlet ergonomic training
Number of subjects: 503

Group type: COMPARATOR
Intervention: Lecture ergonomic training
Number of subjects: 503
Study: 23622007

Group type: EXPERIMENTAL
Intervention: Aeroneb (MMAD, 5 μm)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Aeroneb (MMAD, 3.0 μm)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Wright nebulizer (MMAD, 1.0 μm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Comparison across all particle sizes
Number of subjects: 8
Study: 20525995

Group type: EXPERIMENTAL
Intervention: Dasatinib 100 mg once daily
Number of subjects: 519

Group type: COMPARATOR
Intervention: Imatinib 400 mg once daily
Number of subjects: 519
Study: 18391266

Group type: EXPERIMENTAL
Intervention: Virtual patient system
Number of subjects: 23
Study: 16791612

Group type: EXPERIMENTAL
Intervention: Topical hydrocortisone (HC)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (Vaseline)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Topical hydrocortisone (HC) with physiotherapy (PT)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Infants with retractile prepuces
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Infants with nonretractile prepuces
Number of subjects: 78
Study: 12659547

Group type: EXPERIMENTAL
Intervention: Combined therapy (pharmacotherapy and psychodynamic supportive psychotherapy)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 72
Study: 11069573

Group type: EXPERIMENTAL
Intervention: Mannitol powder
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham provocation
Number of subjects: 30
Study: 9189727

Group type: COMPARATOR
Intervention: Normal diet (NORM) for 3 days, 426 (137) g.day‐1 CHO [5.9 (1.4) g.kg‐1 body mass (BM)]
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Additional carbohydrate (SUPP) for 3 days, 661 (76) g.day‐1 CHO [9.3 (0.7) g.kg‐1 BM]
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal diet (NORM)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Additional carbohydrate (SUPP)
Number of subjects: 6
Study: 1556286

Group type: EXPERIMENTAL
Intervention: School-based social competence training (20-session program)
Number of subjects: 282
Study: 3104123

Group type: EXPERIMENTAL
Intervention: Transdermal Therapeutic System releasing 10 mg of nitroglycerin over 24 hours (TTS 10)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sublingual isosorbide dinitrate 5 mg (ISDN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30951193

Group type: EXPERIMENTAL
Intervention: axitinib plus dalantercept
Number of subjects: 124

Group type: COMPARATOR
Intervention: placebo plus axitinib
Number of subjects: 124
Study: 28342389

Group type: EXPERIMENTAL
Intervention: Elective caesarean section at 38 gestational weeks after a course of corticosteroids
Number of subjects: 200

Group type: COMPARATOR
Intervention: Elective caesarean section at 39 weeks
Number of subjects: 200
Study: 26122982

Group type: EXPERIMENTAL
Intervention: Intervention package delivered by community midwives including psychoeducation, problem solving treatment, and parenting skills, with clinical support via mobile phone.
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Intervention package delivered by community midwives.
Number of subjects: 686

Group type: COMPARATOR
Intervention: Care as usual enhanced by further training of providers in recognition and standard treatment of depression.
Number of subjects: 686
Study: 23541458

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8122

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 8122
Study: 20512335

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GJ) consumed 200 mL three times a day for three days prior to PK analysis.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Midazolam as a phenotypic probe for CYP3A4 activity.
Number of subjects: 8
Study: 19751620

Group type: EXPERIMENTAL
Intervention: Perpetrators of IPV (Perps)
Number of subjects: 236
Study: 16919213

Group type: EXPERIMENTAL
Intervention: Foot orthoses
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Foot orthoses and night splints
Number of subjects: 43

Group type: COMPARATOR
Intervention: Night splints alone
Number of subjects: 43
Study: 14767810

Group type: EXPERIMENTAL
Intervention: IL-4 -589-C/T polymorphism
Number of subjects: 1043
Study: 11729382

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 541

Group type: COMPARATOR
Intervention: Chemoradiation
Number of subjects: 541

Group type: COMPARATOR
Intervention: R1 resection margin status
Number of subjects: 541
Study: 9044491

Group type: EXPERIMENTAL
Intervention: Open palm technique
Number of subjects: 45

Group type: COMPARATOR
Intervention: Single resuscitator technique
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Two resuscitators technique
Number of subjects: 45
Study: 7910880

Group type: EXPERIMENTAL
Intervention: Regular salbutamol (2 puffs - 200 micrograms - four times daily)
Number of subjects: 341
Study: 2853163

Group type: EXPERIMENTAL
Intervention: Particulate Hydroxylapatite (20 mesh)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cone form Hydroxylapatite
Number of subjects: 0
Study: 30149444

Group type: COMPARATOR
Intervention: Nostalgia (Experiment 1)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Nostalgia induced by music (Experiment 2)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Nostalgia (Experiment 3)
Number of subjects: 106
Study: 26292692

Group type: EXPERIMENTAL
Intervention: Full-movement neuromuscular electrical stimulation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control, sensory threshold-neuromuscular electrical stimulation, and motor threshold-neuromuscular electrical stimulation
Number of subjects: 72
Study: 24720396

Group type: EXPERIMENTAL
Intervention: Ligature-less brackets with ß-titanium reverse-curve wires (0.017 x 0.025 inch)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional brackets with Elgiloy multiloop wires (0.016 x 0.022 inch)
Number of subjects: 20
Study: 23926329

Group type: EXPERIMENTAL
Intervention: AAQ + PQ
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: DHP + PQ
Number of subjects: 331
Study: 20193095

Group type: EXPERIMENTAL
Intervention: Vitamin D (10 microg daily)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vitamin D (10 microg daily) + Calcium (600 mg daily)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient (including 10 microg Vitamin D) + Calcium (600 mg daily)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 18641816

Group type: EXPERIMENTAL
Intervention: Monocurve contact lenses
Number of subjects: 126

Group type: COMPARATOR
Intervention: Bicurve Soper-McGuire design contact lenses
Number of subjects: 126
Study: 16511419

Group type: EXPERIMENTAL
Intervention: Cellular telephone intervention (8 counseling sessions plus usual care)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Usual care (brief physician advice, self-help materials, nicotine replacement therapy)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cellular telephone intervention
Number of subjects: 95
Study: 14570667

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture (2‐mA constant current, 1 Hz monophasic)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional manual auricular acupuncture (no electrical stimulation)
Number of subjects: 21
Study: 11011651

Group type: EXPERIMENTAL
Intervention: Home Talk - disease-specific monitoring system with automated questions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy Talk - age-specific automated health screens
Number of subjects: 0
Study: 8838965

Group type: EXPERIMENTAL
Intervention: Intravenous ampicillin (5 g loading dose, intravenous infusion twice, 4 h apart)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (intravenous infusion)
Number of subjects: 102
Study: 1426389

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) after ovarian stimulation with human menopausal gonadotropin (hMG)
Number of subjects: 84
Study: 6342752

Group type: EXPERIMENTAL
Intervention: Primary radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 0
Study: 29608125

Group type: EXPERIMENTAL
Intervention: Kinesiologic tape (KT) applied to spinal nerves T10‐L1 and S2‐S4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG) with tape applied to spinal nerves T1‐T4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study: 30446421

Group type: EXPERIMENTAL
Intervention: Multimodal interventions tailored to individual patients
Number of subjects: 0
Study: 25496083

Group type: EXPERIMENTAL
Intervention: Active laser (LLLT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo laser (Placebo)
Number of subjects: 7
Study: 18983869

Group type: EXPERIMENTAL
Intervention: Monocular and binocular slant cues
Number of subjects: 0
Study: 15122953

Group type: EXPERIMENTAL
Intervention: Regular nicotine brand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low nicotine brand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instructions told regular nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instructions told low nicotine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low nicotine (placebo effect)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular nicotine
Number of subjects: 0
Study: 11181093

Group type: EXPERIMENTAL
Intervention: Yoga (specific techniques not detailed)
Number of subjects: 0